BACKGROUND: The SCORing Atopic Dermatitis (SCORAD) index is used worldwide to assess the severity of atopic eczema. Patient involvement in the treatment process is of major current interest. There are very few validated patient self-assessment tools for atopic dermatitis (AD). OBJECTIVE: To develop a self-assessment score for AD patients, the patient-oriented SCORAD (PO-SCORAD) based on the SCORAD index, and to assess its acceptability in a pilot study. METHODS: A multicenter working group decided on the initial form of the PO-SCORAD. A prospective, single-center pilot study was then carried out to assess its acceptability and validity. A SCORAD and a PO-SCORAD were applied at baseline and after 18 days; the acceptability of the tool was assessed by questionnaire, its validity by comparing SCORAD and PO-SCORAD on both visits. RESULTS: The study involved 15 children and 18 adults. 80% of the respondents found the questions clear and the form easy to fill in; 96% spent less than 10 min on it. A correlation was found between the SCORAD and the PO-SCORAD. CONCLUSION: This study shows that self-assessment is feasible in AD, and that there is a correlation between the physician and the patient scores. This study was the first step in validating the PO-SCORAD. 2009 S. Karger AG, Basel
BACKGROUND: The SCORing Atopic Dermatitis (SCORAD) index is used worldwide to assess the severity of atopic eczema. Patient involvement in the treatment process is of major current interest. There are very few validated patient self-assessment tools for atopic dermatitis (AD). OBJECTIVE: To develop a self-assessment score for ADpatients, the patient-oriented SCORAD (PO-SCORAD) based on the SCORAD index, and to assess its acceptability in a pilot study. METHODS: A multicenter working group decided on the initial form of the PO-SCORAD. A prospective, single-center pilot study was then carried out to assess its acceptability and validity. A SCORAD and a PO-SCORAD were applied at baseline and after 18 days; the acceptability of the tool was assessed by questionnaire, its validity by comparing SCORAD and PO-SCORAD on both visits. RESULTS: The study involved 15 children and 18 adults. 80% of the respondents found the questions clear and the form easy to fill in; 96% spent less than 10 min on it. A correlation was found between the SCORAD and the PO-SCORAD. CONCLUSION: This study shows that self-assessment is feasible in AD, and that there is a correlation between the physician and the patient scores. This study was the first step in validating the PO-SCORAD. 2009 S. Karger AG, Basel
Authors: Nicholas Shortt; Alexander Martin; Kyley Kerse; Gabrielle Shortt; Iva Vakalalabure; Luke Barker; Joseph Singer; Bianca Black; Angela Liu; Allie Eathorne; Mark Weatherall; Marius Rademaker; Mike Armour; Richard Beasley; Alex Semprini Journal: EClinicalMedicine Date: 2022-07-15
Authors: Stephanie J Lax; Jane Harvey; Emma Axon; Laura Howells; Miriam Santer; Matthew J Ridd; Sandra Lawton; Sinéad Langan; Amanda Roberts; Amina Ahmed; Ingrid Muller; Long Chiau Ming; Saumya Panda; Pavel Chernyshov; Ben Carter; Hywel C Williams; Kim S Thomas; Joanne R Chalmers Journal: Cochrane Database Syst Rev Date: 2022-03-11
Authors: Hsiewe Ying Tan; Anthony L Zhang; Charlie C Xue; Dacan Chen; Cliff Da Costa; George B Lenon Journal: BMJ Open Date: 2013-12-30 Impact factor: 2.692
Authors: O Faye; A P Meledie N'Djong; S Diadie; S Coniquet; P A Niamba; F Atadokpede; P Yao Yoboue; M Thierno Dieng; A Zkik; C Castagne; F Zumaglini; A Delarue Journal: J Eur Acad Dermatol Venereol Date: 2019-11-07 Impact factor: 6.166
Authors: Trisha Kaundinya; Uros Rakita; Armaan Guraya; Donna Maria Abboud; Emily Croce; Jacob P Thyssen; Andrew Alexis; Jonathan I Silverberg Journal: J Invest Dermatol Date: 2021-08-02 Impact factor: 8.551